← Leaderboards
Kenneth J Smith
University Of Pittsburgh At Pittsburgh
$6,208,587
Attributed
$7,001,104
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $722.5K · FY2005–23$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,812,192 · 4
AHRQ$1,188,912 · 1
By mechanism
R01$5,305,888 · 3
R18$1,188,912 · 1
K23$506,304 · 1
Top collaborators
- Richard K Zimmerman5 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Richard K Zimmerman$30,590,376
- Amber E Barnato$5,775,266
- Louis D Falo$30,012,458
- Jessica S Merlin$11,212,318
- Bryna J Harwood$665,846
Others in their field
Top investigators on “Epidemiology”
- David Heimbrook · Leidos Biomedical Research, Inc.$390,770,069
- George R Seage · Abt Associates, Inc.$299,251,523
- Jeffrey P Krischer · University Of South Florida$264,076,260
- Barbara Driver · Westat, Inc.$221,167,491
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,739,528
- James Dennis Neaton · Northwestern University$203,539,316
Research focus
EpidemiologyFuturePoliciesCost EffectivenessVaccinationVaccination StrategyCohortVaccinesRecommendationResourcesBaseHerd ImmunityCenters For Disease Control And Prevention (U.S.)EffectivenessClinical TrialsCostProgramsChildDecision MakingElderlyCost Effectiveness AnalysisDisorder RiskPersonsVaccinated
Grant awards (24)
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$397,500
R01 · FY2023 · AI · contact PI
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$396,980
R01 · FY2022 · AI · contact PI
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$391,250
R01 · FY2021 · AI · contact PI
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$391,250
R01 · FY2020 · AI · contact PI
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$313,000
R01 · FY2019 · AI · contact PI
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$311,667
R01 · FY2018 · AI · contact PI
Future of influenza vaccine strategies given interference and choice$394,640
R01 · FY2017 · GM
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$309,000
R01 · FY2017 · AI · contact PI
Future of influenza vaccine strategies given interference and choice$376,939
R01 · FY2016 · GM
Analyzing Adult Pneumococcal Vaccination Implementation in the Underserved$308,000
R01 · FY2016 · AI · contact PI
Future of influenza vaccine strategies given interference and choice$37,588
R01 · FY2016 · GM
Future of influenza vaccine strategies given interference and choice$374,915
R01 · FY2015 · GM
Future of influenza vaccine strategies given interference and choice$400,953
R01 · FY2014 · GM
Virtual Continuity and its Impact on Complex Hospitalized Patients' Care$409,251
R18 · FY2011 · HS · contact PI
Alternative Strategies for Adult Pneumococcal Vaccination$222,728
R01 · FY2011 · AI · contact PI
Virtual Continuity and its Impact on Complex Hospitalized Patients' Care$396,409
R18 · FY2010 · HS · contact PI
Alternative Strategies for Adult Pneumococcal Vaccination$224,978
R01 · FY2010 · AI · contact PI
Virtual Continuity and its Impact on Complex Hospitalized Patients' Care$383,252
R18 · FY2009 · HS · contact PI
Alternative Strategies for Adult Pneumococcal Vaccination$227,250
R01 · FY2009 · AI · contact PI
Alternative Strategies for Adult Pneumococcal Vaccination$227,250
R01 · FY2008 · AI · contact PI
Optimal Strategies for PID Prevention and Management$126,576
K23 · FY2007 · AI · contact PI
Optimal Strategies for PID Prevention and Management$126,576
K23 · FY2006 · AI · contact PI
Optimal Strategies for PID Prevention and Management$126,576
K23 · FY2005 · AI
Optimal Strategies for PID Prevention and Management$126,576
K23 · FY2004 · AI